This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second Look: Comparing the use of Acthar Gel and Cortrophin
Ticker(s): MNKWho's the expert?
Institution: Good Samaritan Hospital
- Rheumatologist in Private Practice | Arthritis and Rheumatism Center, Los Gatos, CA
- Treats approximately ~750 patients (20 on Acthar)
- Board Certified in Rheumatology & Internal Medicine
Interview GoalDiscussing decision making process regarding cortrophin use vis-à-vis Acthar gel, pricing considerations, and if there is a need for additional data
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
